Valeant stock plunge shows the risk of following the leader

Steven Davidoff Solomon writes for The New York Times, Oct. 27, 2015

The recent turmoil in the shares of Valeant Pharmaceuticals International reveals a dangerous tendency of these funds to engage in herd behavior, following the crowd as they plunge in and out of a stock.